Prosecution Insights
Last updated: April 19, 2026
Application No. 18/029,839

MICROFLUIDIC CELL CULTURE DEVICE

Non-Final OA §102
Filed
Mar 31, 2023
Examiner
HERON, VELVET ELIZABETH
Art Unit
1798
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Micronit Holding B V
OA Round
1 (Non-Final)
44%
Grant Probability
Moderate
1-2
OA Rounds
3y 11m
To Grant
99%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allow Rate
4 granted / 9 resolved
-20.6% vs TC avg
Strong +71% interview lift
Without
With
+71.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
45 currently pending
Career history
54
Total Applications
across all art units

Statute-Specific Performance

§101
2.8%
-37.2% vs TC avg
§103
47.5%
+7.5% vs TC avg
§102
23.2%
-16.8% vs TC avg
§112
24.4%
-15.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 9 resolved cases

Office Action

§102
Detailed Action Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Claims 20-37 and 39 in the reply filed on 12/05/2025 is acknowledged. Claim 14 and 15 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected method, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 12/05/2025. Claims 1-13 are pending examination in this response. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-13 are is rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Sugiura et. al. (US 20190093059 A1). Regarding claim 1, Sugiura teaches “A microfluidic cell culture device” (Title and Para [0085], cell culture device. The micro-flow path.); “comprising a body” (Fig. 6 and Para [0194], tank main body12B and lid portion13B ) “wherein said body comprises a fluid system” (Figs. 5-7) “comprising a first fluid chamber” (Para [0062], first culture liquid storage chamber 1); ”a second fluid chamber” (Para [0062], second culture liquid storage chamber 2); “a cell culture chamber” (Para [0062], culture liquid main chamber 3); “and a flow channel” (Para [0062], a culture liquid introduction flow path 5); “for allowing a flow of fluid from said first chamber, via said cell culture chamber, towards said second chamber upon coupling of a pressure pump system” (Para [0102], pressurizing pump 14) “to said fluid system;” [0109] Due to the pressure increase in the first culture liquid storage chamber 1, the culture liquid C1 in the first culture liquid storage chamber 1 is introduced into the circulation space 3a of the culture liquid main chamber 3 through the culture liquid introduction flow path 5. The culture liquid C1 in the circulation space 3a is introduced into the second culture liquid storage chamber 2 through the culture liquid lead-out flow path 6.); “wherein the fluid system further comprises a return channel” (Para [0062], a communication flow path 7.); “formed in said body allowing a flow of fluid from said second chamber to said first chamber.” (Para [0111], using the pressurizing pump 14 to pressurize the inside of each chamber, the culture liquid C1 in the second culture liquid storage chamber 2 is introduced into the first culture liquid storage chamber 1 through the communication flow path 7 due to the pressure increase in the second culture liquid storage chamber 2.). Regarding claim 2, Sugiura teaches all of claim 1 as above in addition to “further comprising a fluid directing mechanism arranged for providing a substantially unidirectional flow in the flow channel.” (Para [0032], The cell culture device according to (6), in which the backflow prevention mechanism is a check valve which allows the flow of the culture liquid in a direction from the culture liquid lead-out flow path to the second culture liquid storage chamber and prevents flow in an opposite direction thereof.). Therefore the flow is in the direction from culture liquid lead-out flow path to the second culture liquid storage chamber which is where the flow channel is located in that flow direction. Regarding claim 3, Sugiura teaches all of claim 2 as above in addition to “wherein the fluid directing mechanism comprises at least one valve provided in at least one of the return channel and the flow channel.” (Fig. 4, Paras [0080] and [0081], A Laplace valve 31 which allows flow of a liquid from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 (flow channel) and prevents inflow of gas from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 is provided at one end of the culture liquid introduction flow path 5 in the first culture liquid storage chamber 1. A check valve 32 which allows flow of a liquid in a direction from the communication flow path 7 (return channel) to the first culture liquid storage chamber 1 and prevents flow in an opposite direction thereof is provided at the other end of the communication flow path 7 in the first culture liquid storage chamber 1. Regarding claim 4, Sugiura teaches all of claim 3 as above in addition to, “wherein the fluid directing mechanism comprises at least one pneumatic valve.” (Paras [0080] and [0102], A Laplace valve 31 which allows flow of a liquid from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 and prevents inflow of gas from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 is provided at one end of the culture liquid introduction flow path 5 in the first culture liquid storage chamber 1. The pressurizing pump 14 is, for example, a compressor.) Therefore the control of gas by preventing inflow of gas from the first culture liquid storage chamber teaches to the valve being pneumatic. Regarding claim 5, Sugiura teaches all of claim 3 as above in addition to “wherein the fluid directing mechanism comprises at least one one-way valve.” (Para [0032], The cell culture device according to (6), in which the backflow prevention mechanism is a check valve which allows the flow of the culture liquid in a direction from the culture liquid lead-out flow path to the second culture liquid storage chamber and prevents flow in an opposite direction thereof.). Regarding claim 6, Sugiura teaches all of claim 5 as above in addition to “ wherein the one-way valve comprises a microfluidic passive check valve.” (Para [0085], Under such a condition, the micro-flow path can be treated as a passive air inflow prevention mechanism.). Regarding claim 7, Sugiura teaches all of claim 3 as above in addition to “wherein the valve is arranged in a upstream region of the respective channel.” (Fig. 4, Paras [0080], A Laplace valve 31 which allows flow of a liquid from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 (flow channel) and prevents inflow of gas from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 is provided at one end of the culture liquid introduction flow path 5 in the first culture liquid storage chamber 1.) Therefore the valve is upstream the flow channel. Regarding claim 8, Sugiura teaches all of claim 3 as above in addition to “wherein both the flow channel and the return channel are provided with a valve.” (Fig. 4, Paras [0080] and [0081], A Laplace valve 31 which allows flow of a liquid from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 (flow channel) and prevents inflow of gas from the first culture liquid storage chamber 1 to the culture liquid introduction flow path 5 is provided at one end of the culture liquid introduction flow path 5 in the first culture liquid storage chamber 1. A check valve 32 which allows flow of a liquid in a direction from the communication flow path 7 (return channel) to the first culture liquid storage chamber 1 and prevents flow in an opposite direction thereof is provided at the other end of the communication flow path 7 in the first culture liquid storage chamber 1.). Regarding claim 9, Sugiura teaches all of claim 1 as above in addition to “wherein at least one of the first and the second chambers are arranged to be coupled to a pump system for pressurizing at least one of the first and the second chambers.” (Para [0108], The pressurizing pump 14 is operated to pressurize the inside of the first culture liquid storage chamber 1 by supplying gas (for example, air) to the first culture liquid storage chamber 1 through the vent hole 1h.). Regarding claim 10, Sugiura teaches all of claim 9 as above in addition to, “wherein the pump system is a pneumatic pressurization system.” (Para, [0102] The pressurizing pump 14 is, for example, a compressor.) Regarding claim 11, Sugiura teaches all of claim 1 as above in addition to “wherein the cell culture chamber in the body is open towards a surface of the body for receiving a cell culture insert, wherein the cell culture insert and the cell culture chamber in the body together form a substantially closed area.” (Para [0064], [0037], [0137] and [0078], In the storage tank 11, it is possible to form a sampling hole (not shown in the drawings) communicating with the outer surface side space 3b. Accordingly, it is possible to collect a liquid in the outer surface side space 3b through the sampling hole. The culture liquid main chamber 3 is a hollow portion formed in the storage tank 11. A lid portion that airtightly closes openings of the culture liquid main chamber, the first culture liquid storage chamber, and the second culture liquid storage chamber in an openable manner. The lid portion 13 is capable of airtightly closing the opening of the tank main body 12 in an openable manner. Specifically, the lid portion 13 is capable of airtightly closing upper openings 1b and 2b of the first culture liquid storage chamber 1 and the second culture liquid storage chamber 2. An example of a structure in which the lid portion 13 airtightly closes the upper openings 1b and 2b includes a structure in which the lid portion 13 abuts on the upper surface of the tank main body 12 with a packing 15 interposed therebetween, and the packing 15 is provided so as to surround each of the upper openings 1b and 2b. In FIG. 1, the lid portion 13 is shown separately from the tank main body 12. An example of a structure in which the lid portion 13B airtightly closes the upper openings 1b, 2b, 21b, and 22b includes a structure in which the lid portion 13 abuts on the upper surface of the tank main body 12B with a packing 15 interposed therebetween, and the packing 15 is provided so as to surround each of the upper openings 1b, 2b, 21b, and 22b.). Regarding claim 12, Sugiura teaches all of claim 1 as above in addition to “comprising a plurality of separated fluid systems.” (Para [0116], As shown in FIG. 3, a storage tank 11A in the cell culture device 10A has a plurality of cell culture units 9.). Regarding claim 13, Sugiura teaches all of claim 1 as above in addition to “wherein the body comprises a plurality of stacked layers” (Fig. 7); “wherein the fluid system is formed by channels and openings formed in the plurality of layers.” (Para [0183] The wall portion 46 has a plurality of through-hole portions 50 penetratingly formed in a thickness direction. The first culture liquid storage chamber 1, the second culture liquid storage chamber 2, the culture liquid main chamber 3, the first liquid storage chamber 21, and the second liquid storage chamber 22 are spaces partitioned by the through-hole portions 50 and the bottom plate 45. Each of the shapes in the plan views of the chambers 1, 2, 3, 21, 22 is oval.). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to VELVET E HERON whose telephone number is (571)272-1557. The examiner can normally be reached M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles Capozzi can be reached on (571) 270-3638. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /V.E.H./Examiner, Art Unit 1798 /CHARLES CAPOZZI/Supervisory Patent Examiner, Art Unit 1798
Read full office action

Prosecution Timeline

Mar 31, 2023
Application Filed
Jan 24, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12566152
MOBILE SYSTEM FOR CALIBRATING, VERIFYING AND/OR ADJUSTING A SENSOR AND METHOD FOR CALIBRATING, VERIFYING AND/OR ADJUSTING A SENSOR
2y 5m to grant Granted Mar 03, 2026
Patent 12559329
SYSTEM FOR HANDLING BIOLOGICAL TISSUE SAMPLES
2y 5m to grant Granted Feb 24, 2026
Patent 12515219
MICROFLUIDIC CHIP AND ELECTRICAL INTERFACE FOR MICROCHIP ELECTROPHORESIS
2y 5m to grant Granted Jan 06, 2026
Study what changed to get past this examiner. Based on 3 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
44%
Grant Probability
99%
With Interview (+71.4%)
3y 11m
Median Time to Grant
Low
PTA Risk
Based on 9 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month